Drug Profile
Fulranumab
Alternative Names: AMG-403; JNJ-42160443Latest Information Update: 05 Nov 2023
Price :
$50
*
At a glance
- Originator Amgen
- Developer Janssen Pharmaceuticals; Janssen Research & Development; Takeda
- Class Monoclonal antibodies; Non-opioid analgesics; Peptides
- Mechanism of Action Nerve growth factor inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Pain
- Discontinued Back pain; Cancer pain; Musculoskeletal pain; Neuropathic pain